Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03125460 · ClinicalTrials.gov registry record
Clinical Evaluation of a Test for Monitoring the Recurrence of Bladder Cancer
A clinical trial, sponsored by Cepheid.
- Completed
- Registry status
- 424
- Enrollment target
NCT03125460: Completed study, sponsored by Cepheid.
NCT03125460 is a clinical trial that has completed, run by Cepheid. The registered enrollment target is 424 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03125460 has completed, sponsored by Cepheid.
- COMPLETED
- Registry status
- 424 participants
- Enrollment target
Study Summary
The objective of this study is to establish the performance characteristics of an assay that detects the recurrence of bladder cancer in patients previously diagnosed with bladder cancer. The study is conducted at locations within and outside of the United States. Testing is performed on urine specimens provided by eligible enrolled patients. Results from this study will not be used for patient management decisions.
Primary Outcome
Comparison to histology for positive or suspicious cystoscopy
Interventions
- DEVICE Xpert Bladder Cancer Monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 424 participants |
| Start Date | 2016-12 |
| Est. Completion | 2019-05 |
What the finished NCT03125460 record still lists
NCT03125460 is an observational study that tracks outcomes without assigning an intervention. The registered 424 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Xpert Bladder Cancer Monitor is the first listed.
NCT03125460 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03125460 about?
NCT03125460 is a clinical study titled "Clinical Evaluation of a Test for Monitoring the Recurrence of Bladder Cancer". The objective of this study is to establish the performance characteristics of an assay that detects the recurrence of bladder cancer in patients previously diagnosed with bladder cancer. The study is conducted at locations within and outside of the United States. Testing is performed on urine speci...
What is the current status of trial NCT03125460?
This trial is currently completed. The enrollment target is 424 participants. The study started on 2016-12. Estimated completion is 2019-05.
What interventions are being tested in trial NCT03125460?
The interventions under investigation include: Xpert Bladder Cancer Monitor (DEVICE).
Who is sponsoring clinical trial NCT03125460?
This trial is sponsored by Cepheid, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05632770 · 424 participants · NA
A Deployment Focused Pragmatic Trial of Optimal Stepped Care Intervention Targeting PTSD and Comorbidity for Acutely Hospitalized Injury Survivors Treated in US Trauma Care Systems
- NCT05733767 · 424 participants · Phase 2
Smoking Cessation Pharmacotherapy-Nurse Practitioner Led Tobacco Treatment Team Study
- NCT06978127 · 424 participants · NA
Technology Assisted Collaborative Care Intervention to Improve Patient-centered Outcomes in Dialysis Patients
- NCT07140913 · 424 participants · Phase 3
A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia